Japan Myeloma Network

Dr Hiroshi Kosugi - Ogaki Municipal Hospital, Ogaki, Japan
Japan Myeloma Network ( Dr Hiroshi Kosugi - Ogaki Municipal Hospital, Ogaki, Japan )
6 Apr 2013

Myeloma UK

Eric Low - Chief Executive, Myeloma UK
Myeloma UK ( Eric Low - Chief Executive, Myeloma UK )
6 Apr 2013

Hot topics at IMW 2013 - interactive discussion

Prof Philippe Moreau, Prof Jesus San Miguel
Hot topics at IMW 2013 - interactive discussion ( Prof Philippe Moreau, Prof Jesus San Miguel )
6 Apr 2013

Myeloma in Asia

Prof Miles Prince, Prof Kazuyuki Shimizu, Prof Jesus San Miguel
Myeloma in Asia ( Prof Miles Prince, Prof Kazuyuki Shimizu, Prof Jesus San Miguel )
6 Apr 2013

Consolidation and maintenance regimens in multiple myeloma

Prof Philippe Moreau, Prof Gareth Morgan, Prof Michel Cavo, Prof Antonio Palumbo
Consolidation and maintenance regimens in multiple myeloma ( Prof Philippe Moreau, Prof Gareth Morgan, Prof Michel Cavo, Prof Antonio Palumbo )
6 Apr 2013

Whole genome sequencing reveals underlying genetics of multiple myeloma

Dr Jonathan Keats - The Translational Genomics Research Institute (TGen), Phoenix, USA
Whole genome sequencing reveals underlying genetics of multiple myeloma ( Dr Jonathan Keats - The Translational Genomics Research Institute (TGen), Phoenix, USA )
4 Apr 2013

Prediction of relapse in stage I nonseminomatous germ cell tumors by CXCL12

Dr Duncan Gilbert - Sussex Cancer Centre, Brighton , UK
Prediction of relapse in stage I nonseminomatous germ cell tumors by CXCL12 ( Dr Duncan Gilbert - Sussex Cancer Centre, Brighton	, UK )
25 Feb 2013

Advances in multiple myeloma from ASH 2012

Prof Thierry Facon - Centre Hospitalier Universitaire, France
Advances in multiple myeloma from ASH 2012 ( Prof Thierry Facon - Centre Hospitalier Universitaire, France )
20 Dec 2012

Expert overview of hot news in lymphoma from ASH 2012 (2/2)

Prof John Gribben, Prof Myron Czuczman, Prof Wolfram Brugger
Expert overview of hot news in lymphoma from ASH 2012 (2/2) ( Prof John Gribben, Prof Myron Czuczman, Prof Wolfram Brugger )
20 Dec 2012

Expert overview of hot news in lymphoma from ASH 2012 (1/2)

Prof John Gribben, Prof Myron Czuczman, Prof Wolfram Brugger
Expert overview of hot news in lymphoma from ASH 2012 (1/2) ( Prof John Gribben, Prof Myron Czuczman, Prof Wolfram Brugger )
20 Dec 2012

Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (5/5)

Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA
Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (5/5) ( Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA )
20 Dec 2012

Multiple myeloma advances for the future suggested by phase I clinical research

Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA
Multiple myeloma advances for the future suggested by phase I clinical research ( Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA )
20 Dec 2012